¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ JM53sx4&  
v|@EuN14<  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© =%B}8$.|  
urQ<r{$x0  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© N37CAbw0  
E#cu}zi  
1.Co-stimulators (or co-stimulating molecules) hI*6f3Vn(n  
9Fg:   
2.NK-kB iEbW[sX[ 4  
8 k_hX^  
3.Immunoglobulin superfamily X<f4X"y  
V|<'o<h8  
4.antigen-presenting cell (APC) FMitIM*]   
HaRx(p0  
5.death domain gRZ!=z[&  
#fXy4iL l  
6.CCR and CXCR Qz$Wp*  
 l .m #  
7.Lectin (or mitogen) Zj0h0Vt  
4z^~,7J^  
8.Clusters of differentiation, CD) (.b!kfC  
@[Wf!8_  
9.B7 family ${97G#  
BLm}mb#/{  
10.Cytotoxic T lymphocyte, CTL) 'G`xD3 E3,  
>VG*La' c  
11.IL-15 and IL-15 receptor (IL-15R) <d{>[R)  
zY].ZS=7  
12.MHC restriction "i!W(}x+  
I}awembw g  
13.Affinity-chromatography _&]Gw, ~/i  
y"H(F,(N  
14.Cyctosprin A, CsA }t1 q5@QU  
D"{%[;J  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) n+ s=u$%qn  
Q{~;4+ZD  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 9rM#w"E?<  
DH.CAV  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 i{r[zA]$  
uY3?(f#  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ,5x9o"N!  
_gpf9ad  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ mw83pU6  
U:|:Y=O?Q  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© S=$ \S9  
O`;o"\P<  
ÃâÒßѧרҵ£º g c<Y?a-  
}RQHsS  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ]zI*}(adu  
C` 8.8  
Ïû»¯ÄÚ¿Æ£º 6-\M }xq?  
XMLl>w2z  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ j% '~l#nw  
[6nN]U~Y  
ѪҺ²¡Ñ§×¨Òµ£º g? C<@  
A=np ?wc  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»